Is ALEC or ALGS more undervalued in 2026?

CirclFi compares Alector, Inc. (ALEC) and Aligos Therapeutics, Inc. (ALGS) using 13 institutional-grade valuation models. ALEC has a Quality of Company score of 5.7/10 while ALGS scores 4.7/10.

Which is a better buy — ALEC or ALGS?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do ALEC and ALGS valuations compare?

ALEC at $2.15 and ALGS at $5.79 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

ALEC vs ALGS Valuation Comparison 2026 — Intrinsic Value Analysis

ALEC

Biotechnology

Alector, Inc.

Quality

5.7

out of 10

Value Trap

LOW

Price

$2.15

Last close

Models

9/13

Active

ALGS

Biotechnology

Aligos Therapeutics, Inc.

Quality

4.7

out of 10

Value Trap

SAFE

Price

$5.79

Last close

Models

11/13

Active

Model-by-Model Comparison

Model	Type	ALEC Fair Value	ALEC Upside	ALGS Fair Value	ALGS Upside
Bayesian DCF	Intrinsic	$0.66	-69.4%	$3.58	-38.1%
Earnings Power Value	Intrinsic	—	—	$7.96	+30.7%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.93	-56.6%	$0.55	-90.4%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for ALEC vs ALGS — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

ALEC vs ALGS — Which Stock Is More Undervalued?

ALEC scores higher with a 5.7/10 quality rating vs ALGS's 4.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Alector, Inc. (ALEC) and Aligos Therapeutics, Inc. (ALGS) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

ALEC currently trades at $2.15 with a QOC of 5.7/10, while ALGS trades at $5.79 with a QOC of 4.7/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).